Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
Aswathy R. Devan(Amrita Vishwa Vidyapeetham), Lekshmi R. Nath(Rajiv Gandhi Centre for Biotechnology), Bhagyalakshmi Nair(Amrita Institute of Medical Sciences and Research Centre), K Pavithran(Amrita Institute of Medical Sciences and Research Centre), Maneesha Murali(Amrita Vishwa Vidyapeetham)
Cited by 37
Related Papers
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
|Molecular Biology Reports|2021|148
Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease
|Journal of Receptors and Signal Transduction|2020|74
Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma
|Scientific Reports|2016|57
Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review
|Journal of Food Biochemistry|2021|50
The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential
|European journal of medical research|2024|40